ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

Patient Costs In Trials Should Be Paid In Any Reform Plan, DCT Board Write To Shalala

June 18, 1993

Major Changes Being Considered By NCI For FCRA

April 14, 1978

In Brief: Ronald Levy, George Stevenson To Share First Hammer Prize; President Reappoints Hammer

December 3, 1982

NCI To Offer Compromise On Including “Chop-Like Elements” In CCOP, Agrees Consortia “Appropriate”

May 14, 1982

Center Directors, NCI Staff Agree- They Have Problems

November 26, 1976

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

May 23, 1980